2012International Journal of Pathology and Clinical MedicineRequires access

Expression of mRNAs missing in metastasis in primary breast carcinoma and its clinical significance

Zheng Xiong-wei

Open publisher page 0 citations

Abstract

Objective: To detect the expression of missing in metastasis(MIM) in human primary breast carcinoma and to evaluate its correlation with clinicopathological features.Methods: The expression of MIM mRNA was detected by SYBR Green quantitative real-time PCR in 60 samples of primary breast carcinoma and adjacent normal tissues,and its expression level was interpreted in terms of various clinical characteristics.Results: The expression of MIM mRNA in breast carcinoma was higher than that of adjacent tissues(P0.05) and it was associated with lymph node metastasis(P0.01),tumor size,and TNM stages(P0.05),but not age,histological grade,pathological type,ER,PR,CerbB-2 and Ki-67(P0.05).Conclusion: Overexpression of MIM mRNA may be a useful marker to predict metastasis of breast carcinoma.It may served as a biomarker for the prediction of moderate or advanced breast carcinoma,and may also prove to be a potential therapeutic target in breast carcinoma.

About this research paper

What this paper is about

Objective: To detect the expression of missing in metastasis(MIM) in human primary breast carcinoma and to evaluate its correlation with clinicopathological features.Methods: The expression of MIM mRNA was detected by SYBR Green quantitative real-time PCR in 60 samples of primary breast carcinoma and adjacent normal tissues,and its expression level was interpreted in terms of various clinical characteristics.Results: The expression of MIM mRNA in breast carcinoma was higher than that of adjacent tissues(P0.05) and it was associated with lymph node metastasis(P0.01),tumor size,and TNM stages(P0.05),but not age,histological grade,pathological type,ER,PR,CerbB-2 and Ki-67(P0.05).Conclusion: Overexpression of MIM mRNA may be a useful marker to predict metastasis of breast carcinoma.It may served as a biomarker for the prediction of moderate or advanced breast carcinoma,and may also prove to be a potential therapeutic target in breast carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To detect the expression of missing in metastasis(MIM) in human primary breast carcinoma and to evaluate its correlation with clinicopathological features.Methods: The expression of MIM mRNA was detected by SYBR Green quantitative real-time PCR in 60 samples of primary breast carcinoma and adjacent normal tissues,and its expression level was interpreted in terms of various clinical characteristics.Results: The expression of MIM mRNA in breast carcinoma was higher than that of adjacent tissues(P0.05) and it was associated with lymph node metastasis(P0.01),tumor size,and TNM stages(P0.05),but not age,histological grade,pathological type,ER,PR,CerbB-2 and Ki-67(P0.05).Conclusion: Overexpression of MIM mRNA may be a useful marker to predict metastasis of breast carcinoma.It may served as a biomarker for the prediction of moderate or advanced breast carcinoma,and may also prove to be a potential therapeutic target in breast carcinoma.

Key concepts: Breast carcinoma, Metastasis, Clinical significance, Biomarker, Carcinoma, Pathological, Medicine, Breast cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of mRNAs missing in metastasis in primary breast carcinoma and its clinical significance — Research Paper | ScholarLens